Skip to content

Study Protocol for a Smartphone Application-based Intervention for Subthreshold Depression

Study Protocol for a Pilot Randomized Controlled Trial on a Smartphone Application-based Intervention for Subthreshold Depression

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04136041
Enrollment
32
Registered
2019-10-23
Start date
2019-10-29
Completion date
2020-03-05
Last updated
2020-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subthreshold Depression

Brief summary

The investigators plan to conduct a randomized controlled trial to examine whether a Smartphone-based Intervention improves subthreshold depression symptoms compared to no intervention. The purpose of this pilot randomized controlled trial is to investigate the feasibility of the final randomized controlled trial.

Interventions

DEVICESmartphone Application

The experimental group will watch movies using the Smartphone application for at least 10 min a day for 5 weeks.

Sponsors

Kibi International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 Years and older * Males and females * Center for Epidemiologic Studies Depression Scale score ≥16 * Written informed consent prior to participation * Owns a smartphone with the iOS® operating system

Exclusion criteria

* Lifetime history of psychiatric disorders * Currently receiving treatment for a mental health problem from a mental health professional * Experience of a major depressive episode in the 2 weeks prior to the study, as ascertained using the Mini-International Neuropsychiatric Interview * Vision or hearing deficits that negatively impact everyday life

Design outcomes

Primary

MeasureTime frameDescription
Depression severity as measured by the Center for Epidemiologic Studies Depression Scale (CES-D) score.Change from Baseline CES-D at 5 weeksThe CES-D is a 20-item self-report questionnaire used to measure depressive symptoms. The CES-D is a four-point Likert scale, with each item scored from 0 to 3. The total score ranges from 0 to 60 points. The higher the score, the stronger the depressive symptoms.

Secondary

MeasureTime frameDescription
Psychological distress as measured by the Kessler Screening Scale for Psychological Distress (K6) score.Change from Baseline K6 at 5 weeksThe K6 is a 6-item self-report questionnaire used to measure psychological distress. The K6 is a five-point Likert scale, with each item scored from 0 to 4. The total score ranges from 0 to 24 points. The higher the score, the stronger the psychological distress.
Anxiety as measured by the 7-item Generalized Anxiety Disorder Scale (GAD-7).Change from Baseline GAD-7 at 5 weeksThe GAD-7 is a 7-item self-report questionnaire used to measure anxiety. The GAD-7 is a four-point Likert scale, with each item scored from 0 to 3. The total score ranges from 0 to 21 points. The higher the score, the stronger the anxiety.

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026